The following is a summary of “Antibiotics use decreases survival in cutaneous squamous cell carcinoma patients receiving ...

The advent of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment by harnessing the immune system to target and eliminate cancer cells.

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

China: A recent case-control observational study has raised concerns about developing proteinuria in patients undergoing ...

Metastatic colorectal cancer with microsatellite instability-high or mismatch repair-deficient status represents a distinct ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

本文仅供中国大陆地区执业的医学药学专业人士参考，如您非前述专业人士，请离开本页面 本文仅供医疗卫生等专业人士参考审批码：TML0038594，有效期为 2025-01-21 至 2026-01-20，资料过期，视同作废内容策划：方程项目审核：于轩题图来源：图虫创意参考文献：[1]Fan Y, Zhou JY, Zhao Y, et al. Efficacy, safety, and ...

In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with ...